Mimedic: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Mimedic
Largest movements
- Cash +€53,942
up €53,942 (+79.5%), from €67,859 to €121,801
mainly Net result for the year (+€62,052) and Depreciation (+€4,000)
- Tangible fixed assets -€4,000
down €4,000 (-38.2%), from €10,477 to €6,477
- Receivables within one year +€3,190
up €3,190 (+7.2%), from €44,054 to €47,245
of which Trade receivables: +€9,309
- Profit (loss) carried forward +€62,052
up €62,052 (+60.6%), from €102,356 to €164,408
- Tax, wage and social debts -€7,415
down €7,415 (-47.4%), from €15,643 to €8,228
of which Taxes: -€9,966
- Gross operating margin -€50,018
down €50,018 (-37.8%), from €132,442 to €82,424
- Taxes -€12,279
down €12,279 (-43.1%), from €28,500 to €16,221
- Depreciation +€2,477
up €2,477 (+162.6%), from €1,523 to €4,000
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €122,390 | €175,735 | +€53,345 | +43.6% |
| Fixed assets | 21/28 | €10,477 | €6,477 | -€4,000 | -38.2% |
| Tangible fixed assets | 22/27 | €10,477 | €6,477 | -€4,000 | -38.2% |
| Furniture and vehicles | 24 | €10,477 | €6,477 | -€4,000 | -38.2% |
| Current assets | 29/58 | €111,914 | €169,259 | +€57,345 | +51.2% |
| Amounts receivable within one year | 40/41 | €44,054 | €47,245 | +€3,190 | +7.2% |
| Trade receivables | 40 | €27,929 | €37,238 | +€9,309 | +33.3% |
| Other amounts receivable | 41 | €16,125 | €10,007 | -€6,118 | -37.9% |
| Cash at bank and in hand | 54/58 | €67,859 | €121,801 | +€53,942 | +79.5% |
| Deferred charges and accrued income | 490/1 | - | €213 | +€213 | |
| Total equity and liabilities | 10/49 | €122,390 | €175,735 | +€53,345 | +43.6% |
| Equity | 10/15 | €105,356 | €167,408 | +€62,052 | +58.9% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €102,356 | €164,408 | +€62,052 | +60.6% |
| Amounts payable | 17/49 | €17,034 | €8,328 | -€8,707 | -51.1% |
| Amounts payable within one year | 42/48 | €17,034 | €8,328 | -€8,707 | -51.1% |
| Trade debts | 44 | €1,391 | €99 | -€1,292 | -92.9% |
| Suppliers | 440/4 | €1,391 | €99 | -€1,292 | -92.9% |
| Taxes, remuneration and social security | 45 | €15,643 | €8,228 | -€7,415 | -47.4% |
| Taxes | 450/3 | €15,643 | €5,677 | -€9,966 | -63.7% |
| Remuneration and social security | 454/9 | - | €2,551 | +€2,551 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,523 | €4,000 | +€2,477 | +162.6% |
| Other operating charges | 640/8 | €63 | €63 | +€0 | +0.1% |
| Gross operating margin | 9900 | €132,442 | €82,424 | -€50,018 | -37.8% |
| Operating profit (loss) | 9901 | €130,856 | €78,361 | -€52,495 | -40.1% |
| Financial charges | 65/66B | - | €87 | +€87 | |
| Recurring financial charges | 65 | - | €87 | +€87 | |
| Profit (loss) for the period before taxes | 9903 | €130,856 | €78,274 | -€52,582 | -40.2% |
| Income taxes | 67/77 | €28,500 | €16,221 | -€12,279 | -43.1% |
| Profit (loss) for the period | 9904 | €102,356 | €62,052 | -€40,304 | -39.4% |
| Profit (loss) for the period to be appropriated | 9905 | €102,356 | €62,052 | -€40,304 | -39.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.